Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-11-10, Stock:NVS, The news for the past five days is as follows:
2021-11-03: nan
2021-11-04: NEWS1: Novartis' Iptacopan Meets Primary Endpoint Goal In Rare Kidney Disease Trial.NEWS2: New data at ASH spotlight Novartis recently approved Scemblix®, next-generation CAR-T platform and expanding hematology portfolio.NEWS3: Ionis (IONS) Q3 Earnings & Revenues Fall Short of Estimates.NEWS4: Novartis Abandons Stake in Rival Roche for $20.7 Billion.NEWS5: Novartis to Sell Roche Stake for $20.7 Billion.NEWS6: Novartis To Offload Its Stake Back To Roche For $20.7B.NEWS7: After Tame Taper, Powell Shifts Focus Back to Jobs Market.NEWS8: Novartis Unwinds Roche Ties With $20.7 Billion Stake Sale.NEWS9: Novartis Will Sell Back Its Roche Stake for $21 Billion. Both Stocks Are Rising..NEWS10: Energize – A First-of-Its-Kind Program to Increase Access to Renewable Energy for Pharmaceutical Suppliers.NEWS11: UPDATE 2-Roche buys back voting rights from rival Novartis for $20.7 bln.NEWS12: Novartis cuts uneasy 20-year ties to Roche with $20.7 billion voting stake sale.NEWS13: Roche buys back voting rights from rival Novartis for $20.7 billion.NEWS14: Novartis cuts uneasy 20-year ties to Roche with $20.7 billion voting stake sale.NEWS15: Novartis to sell its Roche stake in a bilateral transaction to Roche.NEWS16: European Stock Futures Higher  as Market Digests Federal Reserve Tapering.
2021-11-05: NEWS1: Why Did Deciphera Stock Plunge 70% Today?.NEWS2: UPDATE 1-Roche controlling family won't have to make offer after Novartis deal.NEWS3: Roche controlling family won't have to make offer after Novartis deal.NEWS4: Roche says controlling family won't have to make offer to other shareholders.NEWS5: Roche says controlling family won't have to make offer to other shareholders.
2021-11-08: NEWS1: Exclusive: Startup raises $27M to find brain-based biomarkers.
2021-11-09: NEWS1: Novartis Dumps Another Bispecific Candidate From Xencor Deal.

Answer: Rise